Glutamatergic model psychoses: prediction error, learning, and inference

Corlett, Philip R, Honey, Garry D, Krystal, John H, Fletcher, Paul C·2011·Neuropsychopharmacology
DOI 10.1038/npp.2010.163

Cites (300)

Items 201–296 of 296

  1. Contribution of Cystine–Glutamate Antiporters to the Psychotomimetic Effects of Phencyclidine
    David L. Baker, Aric Madayag, Lars V. Kristiansen, James H. Meador‐Woodruff, Vahram H. Haroutunian, Ilangovan Raju · 2007 · Neuropsychopharmacology
  2. Predictability of stimulus deviance and the mismatch negativity
    Elyse S. Sussman, Walter Ritter, Herbert G. Vaughan · 1998 · Neuroreport
  3. Is there an Epigenetic Component in Long-term Memory?
    Robin Holliday · 1999 · Journal of Theoretical Biology
  4. Changing Concepts in Pain Control During Surgery
    Guenter Corssen, M. MIYASAKA, Edward F. Domino · 1968 · Anesthesia & Analgesia
  5. Further studies with propranolol in psychotic patients
    A Atsmon, Itay Blum, Meir S Steiner, Arje Latz, Henricus Wijsenbeek · 1972 · Psychopharmacology
  6. Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy—a [123I]CNS-1261 SPET study
    Stone, James M., Erlandsson, Kjell, Arstad, Erik, Squassante, Lisa, Teneggi, Vincenzo, Bressan, Rodrigo A., Krystal, John H., Ell, Peter J., Pilowsky, Lyn S. · 2008 · Psychopharmacology
  7. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats
    Christopher Nelson, Joshua A. Burk, John P. Bruno, Martin F. Sarter · 2002 · Psychopharmacology
  8. Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2antagonists
    Rasmussen, Kurt, Aghajanian, George K. · 1986 · Brain Research
  9. Acute Ketamine Administration Alters the Brain Responses to Executive Demands in a Verbal Working Memory Task: an fMRI Study
    Rebekah A. E. Honey, Garry D. Honey, Chris O'Loughlin, S R Sharar, Dharshan Kumaran, Edward Thomas Bullmore, David Krishna Menon, Tim Donovan, Vicky Lupson, R Bisbrown-Chippendale et al. · 2004 · Neuropsychopharmacology
  10. Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo
    Garry D. Honey, Philip Robert Corlett, Anthony Ray Absalom, Michael Lee, Edith Pomarol‐Clotet, Graham K. Murray, Peter J. McKenna, Edward Thomas Bullmore, David Krishna Menon, Paul Charles Fletcher · 2008 · Journal of Neuroscience
  11. Positive Allosteric Modulation of Metabotropic Glutamate 5 (mGlu5) Receptors Reverses N-Methyl-D-Aspartate Antagonist-Induced Alteration of Neuronal Firing in Prefrontal Cortex
    Lucas Lecourtier, Houman Homayoun, Gilles D. Tamagnan, Bita Moghaddam · 2007 · Biological Psychiatry
  12. Prediction Error during Retrospective Revaluation of Causal Associations in HumansfMRI Evidence in Favor of an Associative Model of Learning
    Philip Robert Corlett, Michael R. F. Aitken, Anthony Dickinson, David R. Shanks, Garry D. Honey, Rebekah A. E. Honey, Trevor William Robbins, Edward Thomas Bullmore, Paul Charles Fletcher · 2004 · Neuron
  13. Spontaneous confabulation, reality monitoring, and the limbic system — a review
    Armin Schnider · 2001 · Brain Research Reviews
  14. NMDA and AMPA receptors on neocortical neurons are differentially distributed
    Hans‐Ulrich Dodt, Andreas Frick, Knut K. W. Kampe, W. Zieglgänsberger · 1998 · European Journal of Neuroscience
  15. When less is more and when more is more: The mediating roles of capacity and speed in brain-behavior efficiency
    Bart Rypma, Vivek Prabhakaran · 2009 · Intelligence
  16. The Role of the Lateral Frontal Cortex in Causal Associative Learning: Exploring Preventative and Super-learning
    Turner, D. C. · 2004 · Cerebral Cortex
  17. Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness
    Koethe, Dagmar, Gerth, Christoph W., Neatby, Miriam A., Haensel, Anita, Thies, Martin, Schneider, Udo, Emrich, Hinderk M., Klosterkötter, Joachim, Schultze-Lutter, Frauke, Leweke, F. Markus · 2006 · Schizophrenia Research
  18. Phencyclidine: an overview.
    R C Petersen, Richard C. Stillman · 1978 · PubMed
  19. Chaotic behavior in dopamine neurodynamics.
    Roy King, Jack D. Barchas, Bernardo A. Huberman · 1984 · Proceedings of the National Academy of Sciences
  20. A neurocomputational approach to delusions
    Manfred Spitzer · 1995 · Comprehensive Psychiatry
  21. A NEW DRUG CAUSING SYMPTOMS OF SENSORY DEPRIVATION Neurological, Electroencephalographic and Pharmalogical Effects of Sernyl
    John Stirling Meyer, FERDINAND E. GREIFENSTEIN, M. DEVAULT · 1959 · The Journal of Nervous and Mental Disease
  22. New Perspectives in the Studies on Endocannabinoid and Cannabis: Abnormal Behaviors Associate With CB1 Cannabinoid Receptor and Development of Therapeutic Application
    Michihiro Fujiwara, Nobuaki Egashira · 2004 · Journal of Pharmacological Sciences
  23. Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
    Lawrence S. Kegeles, Yolanda Zea‐Ponce, Anissa Abi‐Dargham, Janine Rodenhiser, Theodore Wang, Richard Weiss, Ronald L. Van Heertum, Joseph John Mann, Marc Laruelle · 1999 · Synapse
  24. Selected writings of Hermann von Helmholtz
    Hermann L. F. Helmholtz, Russell Kahl · 1971 · Medical Entomology and Zoology
  25. Bayesian network models of causal learning
    Michael R. Waldmann, Laura F. Martignon · 1998 · Max Planck Institute for Plasma Physics
  26. Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for “NMDA antagonist modelling” of schizophrenia
    Gary Gilmour, Elsa Y. Pioli, Sophie L. Dix, Janice W. Smith, Michael W. Conway, Wendy T. Jones, Sally Loomis, Rebecca Mason, Shahram Shahabi, Mark David Tricklebank · 2009 · Psychopharmacology
  27. Attentional bias to incentive stimuli in frequent ketamine users
    Celia J. A. Morgan, H. Rees, H. Valerie Curran · 2008 · Psychological Medicine
  28. Hallucinogen-Induced UP States in the Brain Slice of Rat Prefrontal Cortex: Role of Glutamate Spillover and NR2B-NMDA Receptors
    Lambe, Evelyn K, Aghajanian, George K · 2006 · Neuropsychopharmacology
  29. “The seven sins” of the Hebbian synapse: Can the hypothesis of synaptic plasticity explain long-term memory consolidation?
    Yuri I. Arshavsky · 2006 · Progress in Neurobiology
  30. Reduced binocular depth inversion in regular cannabis users
    David Michael Semple, Fiona Ramsden, Andrew Mark McIntosh · 2003 · Pharmacology Biochemistry and Behavior
  31. Evidence for Sustained Attention and Working Memory in Schizophrenia Sharing a Common Mechanism
    Henry Silver, Pablo Feldman · 2005 · Journal of Neuropsychiatry
  32. Bayesian spiking neurons II: learning
    Deneve, Sophie · 2008 · Neural Computation
  33. The functional neuroanatomy of schizophrenic subsyndromes
    Garry D. Honey, T. Sharma, John Suckling A, Vincent Giampietro, William Soni, Steven Williams, Edward Thomas Bullmore · 2003 · Psychological Medicine
  34. Angel's Trumpet psychosis: a central nervous system anticholinergic syndrome
    Richard C.W. Hall, Michael K. Popkin, L E Mchenry · 1977 · American Journal of Psychiatry
  35. Signs and symptoms in the pre-psychotic phase: description and implications for diagnostic trajectories
    S. Iyer, L. Boekestyn, Clifford Cassidy, Suzanne King, R. Joober, A. Malla · 2008 · Psychological Medicine
  36. Impairment of specific episodic memory processes by sub-psychotic doses of ketamine: the effects of levels of processing at encoding and of the subsequent retrieval task
    Garry D. Honey, Rebekah A. E. Honey, Sam R. Sharar, Danielle C. Turner, Edith Pomarol‐Clotet, Dharshan Kumaran, Jon S. Simons, Xiangen Hu, Michael D. Rugg, Edward Thomas Bullmore et al. · 2005 · Psychopharmacology
  37. Heaven and Hell
    Aldous Huxley · 1956 · Medical Entomology and Zoology
  38. Is There a Schizophasia? A Study Applying the Single Case Approach to Formal Thought Disorder in Schizophrenia
    Tomasina M. Oh, Robert J. McCarthy, Peter J. McKenna · 2002 · Neurocase
  39. NMDA/NR2B Selective Antagonists in the Treatment of Ischemic Brain Injury
    Chen Wang, Ashfaq M Shuaib · 2005 · CNS & Neurological Disorders - Drug Targets
  40. Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment
    Hinderk Meiners Emrich, Matthias M. Weber, A. Wendl, Josef Zihl, Léa Meyer, W. Hanisch · 1991 · Pharmacology Biochemistry and Behavior
  41. The impact of microRNAs and alternative splicing in pharmacogenomics
    Fábio Passetti, Carlos Gil Ferreira, Fabrício Falconi Costa · 2009 · The Pharmacogenomics Journal
  42. The Facts of Perception
    Jennifer J. Freyd · 1991 · Contemporary Psychology
  43. Striatal dopamine receptors and transporters in monkeys with neonatal temporal limbic damage
    A. Heinz, R. Saunders, B. Kolachana, Dixon Jones, J. G. Gorey, J. Bachevalier, Daniel R. Weinberger · 1999 · Synapse
  44. Visual 3D illusion: A systems-theoretical approach to psychosis
    Schmeider, U., Leweke, F. M., Sternemann, U., Emrich, H. M., Weber, M. M. · 1996 · European Archives of Psychiatry and Clinical Neuroscience
  45. A Three-Component-System Hypothesis of Psychosis
    H. M. Emrich · 1989 · The British Journal of Psychiatry
  46. The cognitive neuroscience of agency in schizophrenia
    Henrik Walter, Manfred Spitzer · 2003 · Cambridge University Press eBooks
  47. Pathogenesis of Acute Schizophrenic Psychosis
    Malcolm B. Bowers · 1968 · Archives of General Psychiatry
  48. Towards a General Theory of Neural Computation Based on Prediction by Single Neurons
    Christopher D. Fiorillo · 2008 · PLoS ONE
  49. The self in neuroscience and psychiatry
    Raben Rosenberg · 2004 · Acta Psychiatrica Scandinavica
  50. Polymorphic Polymorphic MicroRNA-Target Interactions: A Novel Source of Phenotypic Variation
    Michel Georges, Alex Clop, Fabienne Marcq, Haruko Takeda, Dimitri Pirottin, Samuel Hiard, Xavier Tordoir, Florian Caiment, Françoise Meish, Bernard B. Bibé et al. · 2006 · Cold Spring Harbor Symposia on Quantitative Biology
  51. Delusions, superstitious conditioning and chaotic dopamine neurodynamics
    Andrew L. Shaner · 1999 · Medical Hypotheses
  52. Glutamate Stimulation of [3H]Dopamine Release from Dissociated Cell Cultures of Rat Ventral Mesencephalon
    Howard T.J. Mount, Sharon A. Welner, Rémi Quirion, Patricia Boksa · 1989 · Journal of Neurochemistry
  53. Semantic Priming after Ketamine Acutely in Healthy Volunteers and Following Chronic Self-Administration in Substance Users
    Celia J. A. Morgan, Susan Lee Rossell, Fiona Pepper, James Smart, James Blackburn, Brigitta Brandner, H. Valerie Curran · 2005 · Biological Psychiatry
  54. Is there a mismatch negativity (MMN) in visual modality?
    Rainer Cammann · 1990 · Behavioral and Brain Sciences
  55. Human visual system automatically represents large-scale sequential regularities
    Motohiro Kimura, Andreas Widmann, Erich Schröger · 2010 · Brain Research
  56. Inbred Mouse Strains Differ in Sensitivity to “Popping” Behavior Elicited by MK-801
    Stephen I. Deutsch, Richard B. Rosse, Steven M. Paul, Raine L. Riggs, John P. Mastropaolo · 1997 · Pharmacology Biochemistry and Behavior
  57. Developing hypnotic analogues of clinical delusions: Mirrored-self misidentification
    Amanda J. Barnier, Rochelle E. Cox, Akira R. O’Connor, Max Coltheart, Robyn A. Langdon, Nora Breen, Martha Turner · 2008 · Cognitive Neuropsychiatry
  58. A PRELIMINARY NOTE ON THE PSYCHIC ACTION OF MESCALIN, WITH SPECIAL REFERENCE TO THE MECHANISM OF VISUAL HALLUCINATIONS
    Alwyn Knauer, William James Maloney · 1913 · The Journal of Nervous and Mental Disease
  59. Dopaminergic Regulation of Striatal Acetylcholine Release: The Critical Role of Acetylcholinesterase Inhibition
    Elio Acquas, H. Christian Fibiger · 1998 · Journal of Neurochemistry
  60. Predictive performance of the Domino, Hijazi, and Clements models during low-dose target-controlled ketamine infusions in healthy volunteers
    Anthony Ray Absalom, Michael Lee, David Krishna Menon, S R Sharar, Tom De Smet, J. Halliday, M. Ogden, Philip Robert Corlett, Garry D. Honey, Paul Charles Fletcher · 2007 · British Journal of Anaesthesia
  61. Apolipoprotein E ɛ4 Allele Increases Risk for Psychotic Symptoms in Alzheimer's Disease
    Kristina F. Zdanys, Timothy Kleiman, Martha G. MacAvoy, Benjamin T. Black, Tracy Rightmer, Monique A. Grey, Katherine S. Garman, Rajesh R. Tampi, Joel E. Gelernter, Christopher H. van Dyck · 2006 · Neuropsychopharmacology
  62. A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia
    M. Sarter, Vicente Martinez, Rouba Kozak · 2008 · Psychopharmacology
  63. Cognitive correlates of schizophrenia signs and symptoms: I. verbal communication disturbances
    Howard Berenbaum, John G. Kerns, Laura L. Vernon, José Jesús Balseiro Gómez · 2008 · Psychiatry Research
  64. Sensorische St�rungen bei Schizophrenien
    Gross, G., Huber, G. · 1972 · Archiv f�r Psychiatrie und Nervenkrankheiten
  65. How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia
    Patrícia Polgár, Márta Farkas, Orsolya Nagy, Ogúz Kelemen, János Réthelyi, István Bitter, Catherine E. Myers, Mark A. Gluck, Szabolcs Kéri · 2007 · Schizophrenia Research
  66. Modeling “psychosis” in vitro by inducing disordered neuronal network activity in cortical brain slices
    George K. Aghajanian · 2009 · Psychopharmacology
  67. Unique pharmacological profile of aripiprazole as the phasic component buster
    Takashi Hamamura, Toshiki Harada · 2007 · Psychopharmacology
  68. The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia
    Garry D. Honey, Chris O'Loughlin, Danielle C. Turner, Edith Pomarol‐Clotet, Philip Robert Corlett, Paul Charles Fletcher · 2005 · Neuropsychopharmacology
  69. Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine
    Hyun Sang Cho, Deepak Cyril D’Souza, Ralitza V. Gueorguieva, Edward Belk Perry, Steven H. Madonick, Laurence P. Karper, Anissa Abi‐Dargham, Ayşenil Belger, Walid Abi‐Saab, Deborah S. Lipschitz et al. · 2005 · Psychopharmacology
  70. Clinical Use of Retrograde Amnesia Produced by Electroconvulsive Shock: A Conditioning Hypothesis
    Richard D. Rubin · 1976 · Canadian Psychiatric Association Journal
  71. N-methyl-d-aspartate receptor inhibition by an apolipoprotein E-derived peptide relies on low-density lipoprotein receptor-associated protein
    Zhenyu Sheng, Mary Prorok, B. Brown, Francis Castellino · 2008 · Neuropharmacology
  72. Does Propranolol have an Antipsychotic Effect?
    Rahul Manchanda, Steven Richard Hirsch · 1986 · The British Journal of Psychiatry
  73. Block of the N-methyl-d-aspartate receptor by phenycyclidine-like drugs is influenced by alternative splicing
    JoséM. Rodríguez-Paz, Vellareddy Anantharam, Steven N. Treistman · 1995 · Neuroscience Letters
  74. Apolipoprotein E ε4 and clinical phenotype in schizophrenia
    David Pickar, Anil K. Malhotra, W Rooney, Alan F. Breier, David A Goldman · 1997 · The Lancet
  75. Mephentermine Psychosis: Misuse of the Wyamine Inhaler
    BURTON M. ANGRIST, Jack W. Schweitzer, S Gershon, Arnold J. Friedhoff · 1970 · American Journal of Psychiatry
  76. Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man
    Torsten Passie, Matthias Karst, Mathias Borsutzky, Birgitt Wiese, Hinderk Meiners Emrich, Udo Schneider · 2003 · Journal of Psychopharmacology
  77. d-amphetamine-induced enhancement of inhibitory mechanisms involved in visual search.
    Mark T. Fillmore, Craig R. Rush, Ben D. Abroms · 2005 · Experimental and Clinical Psychopharmacology
  78. Ketamine Case Study: The Phenomenology of a Ketamine Experience
    Russell Newcombe · 2008 · Addiction Research & Theory
  79. What has (Neuro)Psychology told us About the Mind (so Far)? a Reply to Coltheart (2006)
    Richard N. Henson · 2006 · Cortex
  80. Capgras Syndrome Induced by Ketamine in a Healthy Subject
    Philip Robert Corlett, Deepak Cyril D’Souza, John Harrison Krystal · 2010 · Biological Psychiatry
  81. Superstitious conditioning as a model of delusion formation following chronic but not acute ketamine in humans
    Tom P. Freeman, Celia J. A. Morgan, Elissa B. Klaassen, Ravi Das, Ana Stefanovic, Brigitta Brandner, H. Valerie Curran · 2009 · Psychopharmacology
  82. Expression of NR1, NR2A and NR2B NMDA receptor subunits is not altered in the genetically-inbred Balb/c mouse strain with heightened behavioral sensitivity to MK-801, a noncompetitive NMDA receptor antagonist
    Pin‐Yu Perera, Jack H. Lichy, John P. Mastropaolo, Richard B. Rosse, Stephen I. Deutsch · 2008 · European Neuropsychopharmacology
  83. Is Persistent Ketamine Use a Valid Model of the Cognitive and Oculomotor Deficits in Schizophrenia?
    Celia J. A. Morgan, Vyv C. Huddy, Michelle G. Lipton, H. Valerie Curran, Eileen M. Joyce · 2008 · Biological Psychiatry
  84. Replicated genetic evidence supports a role for HOMER2 in schizophrenia
    William P. Gilks, Emma H. Allott, Gary J Donohoe, Elizabeth Cummings, Michael Gill, Aiden Peter Corvin, Derek W. Morris · 2009 · Neuroscience Letters
  85. Ceci n’est pas une psychose. Toward a Historical Epistemology of Model Psychoses
    Nicolas Langlitz · 2006 · BioSocieties
  86. The Apolipoprotein E ε4 Allele Is Associated with Blunting of Ketamine-Induced Psychosis in Schizophrenia A Preliminary Report
    Anil K. Malhotra · 1998 · Neuropsychopharmacology
  87. An Effective Paradigm for Conditioning Visual Perception in Human Subjects
    Peter Davies, G. L. Davies, Spencer Bennett · 1982 · Perception
  88. Pharmacogenetics: technologies to detect copy number variations.
    Dipali Dhawan, Harish Padh · 2009 · PubMed
  89. NMDA receptor-mediated mechanism of ketamine-induced facilitation of glutamatergic excitatory synaptic transmission
    Eichi Narimatsu, Yurie Kawamata, Mikito Kawamata, Naoyuki Fujimura, Akiyoshi Namiki · 2002 · Brain Research
  90. Persistence of Delusional Content among Psychotics over Consecutive Episodes
    Vinod Kumar Sinha, S.K. Chaturvedi · 2010 · Psychopathology
  91. Bayesian associative learning
    David R. Shanks · 2006 · Trends in Cognitive Sciences
  92. Productive and Creative Research with Man and Dolphin
    John C. Lilly · 1963 · Archives of General Psychiatry
  93. Emotional predisposition to psychotropic drug effects.
    Robert J. Biersner, Joseph A. Harris, David H. Ryman · 1977 · Journal of Consulting and Clinical Psychology
  94. In this issue
    Craig Morgan · 2008 · Psychological Medicine
  95. Emotional predisposition to psychotropic drug effects.
    Robert J. Biersner, Joseph A. Harris, David H. Ryman · 1977 · Journal of Consulting and Clinical Psychology
  96. Untitled work
    1997 · 10.1002/(sici)1098-2396(199707)26:3